Fortrea Holdings Inc. key statistics and ratios
In fiscal 2025, Fortrea Holdings Inc. had return on equity of -102.4% and a net margin of -36.2%. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|
| Net margin | 3.2% | 6.6% | −0.9% | −12.2% | −36.2% | −2.6% |
| Return on equity | 3.0% | 5.6% | −1.0% | −21.4% | −102.4% | −12.5% |
| Return on assets | — | 4.3% | −0.6% | −8.3% | −31.3% | −2.5% |
| Effective tax rate | 28.2% | 22.0% | — | — | — | — |
| SG&A as % of revenue | 9.9% | 14.7% | 15.8% | 20.8% | 16.8% | 15.4% |
Financial health
- Short-term assets cover short-term liabilities $953m of assets due within a year against $983m of liabilities due within a year.
- Short-term assets cover long-term liabilities $953m short-term assets against $1.2bn of longer-dated liabilities.
- More cash than debt $221m of cash against $1.1bn of debt.
- Debt below 40% of shareholders' equity Debt is 198% of equity.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt $202m of operating cash flow against $1.1bn of debt.
- Operating profit covers interest at least five times over Interest not separately reported. Not assessable.
Moat
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.
Compare with peers
- Bio-rad Laboratories, Inc. statistics
- Medpace Holdings, Inc. statistics
- Qiagen N.V. statistics
- Bruker Corp statistics
- Charles River Laboratories statistics
Head to head: BIO vs FTREFTRE vs MEDPFTRE vs QGEN
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies